Our Publications

An ultra-long-acting tenofovir ProTide nanoformulation achieves monthslong HBV suppression

Science Advances
Read the paper

Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation

Nature Communications
Read the paper

CRISPR-Cas9 Mediated Exonic Disruption for HIV-1 Elimination

EBioMedicine
Read the paper

Transformation of tenofovir into stable ProTide nanocrystals with long-acting pharmacokinetic profiles

Nature Communications
Read the paper

Lipophilic Nanocrystal Prodrug-Release Defines the Extended Pharmacokinetic Profiles of a Year-Long Cabotegravir

Nature Communications
Read the paper

A year-long extended release nanoformulated cabotegravir prodrug

Nature Materials
Read the paper

News and Views: Long-acting antiretroviral therapy

Nature Materials
Read the paper

Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized Mice

Nature Communications
Read the paper

Research Highlights: CRISPR helps to rid mice of HIV

Nature
Read the paper

Creation of a long-acting rilpivirine prodrug nanoformulation

Journal of Controlled Release
Read the paper

Synthesis of a long acting nanoformulated emtricitabine ProTide

Biomaterials
Read the paper